P71. Tamoxifen therapy stabilized cell membrane permeability for LDH in PBL of breast cancer patients

Jurisic Vladimir; Konjevic Gordana; Neskovic-Konstantinovic Zora; Neskovic Borka Spuzic Ivan

首页> 外文期刊>European Journal of Cancer Supplements >P71. Tamoxifen therapy stabilized cell membrane permeability for LDH in PBL of breast cancer patients

【24h】

P71. Tamoxifen therapy stabilized cell membrane permeability for LDH in PBL of breast cancer patients

机译：P71。他莫昔芬疗法可稳定乳腺癌患者PBL中LDH的细胞膜通透性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第6期|共1页
作者
Jurisic Vladimir; Konjevic Gordana; Neskovic-Konstantinovic Zora; Neskovic Borka Spuzic Ivan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer. [J] . Boccardo F, Guglielmini P, Parodi A, Breast cancer research and treatment. . 2011,第3期

机译：淋巴结阳性，雌激素受体阳性的乳腺癌患者的化学疗法与他莫昔芬对比化学疗法加他莫昔芬。早期乳腺癌中“每化学或每单化学性厌食症（GROCTA）的研究结果” 01试验的最新结果。
2. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer. [J] . Boccardo F, Guglielmini P, Parodi A, Breast cancer research and treatment. . 2011,第3期

机译：淋巴结阳性，雌激素受体阳性的乳腺癌患者的化学疗法与他莫昔芬对比化学疗法加他莫昔芬。早期乳腺癌中“每化学或每单化学性厌食症（GROCTA）的研究结果” 01试验的最新结果。
3. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the ‘gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)’ 01-Trial in early breast cancer [J] . Francesco Boccardo, Pamela Guglielmini, Andrea Parodi, Breast Cancer Research and Treatment . 2011,第3期

机译：淋巴结阳性，雌激素受体阳性的乳腺癌患者的化学疗法与他莫昔芬对比化疗加他莫昔芬的关系。早期乳腺癌“ gruppo di ricerca per la chemio-ormonoterapia adiuvante（GROCTA）” 01试验的最新结果
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Tamoxifen use, adherence to therapy, and quality of life in older breast cancer patients. [D] . Newell, Debra Ann. 2003

机译：他莫昔芬的使用，对治疗的依从性以及老年乳腺癌患者的生活质量。
6. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. [O] . P. Lissoni, S. Barni, S. Meregalli, 1995

机译：褪黑激素对癌症内分泌治疗的调节作用：他莫昔芬加褪黑激素在仅接受他莫昔芬治疗的转移性乳腺癌患者中进行的II期研究。
7. P71. Tamoxifen therapy stabilized cell membrane permeability for LDH in PBL of breast cancer patients [O] . Vladimir Jurisic, Gordana Konjevic, Zora Neskovic-Konstantinovic, 2006

机译：P71。他莫昔芬疗法可稳定乳腺癌患者PBL中LDH的细胞膜通透性

P71. Tamoxifen therapy stabilized cell membrane permeability for LDH in PBL of breast cancer patients

著录项

相似文献

相关主题

期刊订阅